Julien Harneis & Merck Group

Julien Harneis: Senior UN Ebola coordinator, providing key updates and urging international support. His statements shape global awareness and funding decisions.

Merck Group: Merck Group's Ervebo vaccine is being deployed in the outbreak response, potentially increasing sales. However, its efficacy against the Bundibugyo strain is unproven, and the trial outcome will be critical.

Julien Harneis: Julien Harneis, as UN senior Ebola coordinator, is warning of exponential growth, influencing international awareness and response. His statements highlight the urgency.

Merck Group: Merck Group is the developer of Ervebo, the only approved Ebola vaccine, which is being deployed in the DRC outbreak. Its role is central, and successful cross-protection could expand its market and reputation.

Julien Harneis: UN senior Ebola coordinator, urging more action. His role is to coordinate UN efforts.

Merck Group: Manufacturer of RVSV-ZEBOV vaccine, which is being considered for cross-protection trials. Its vaccine could play a role in the response, benefiting its reputation.